Clinical Trial Update: Pregabalin Trial In HIV Neuropathic Pain [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of pregabalin for HIV-associated neuropathic pain was terminated; results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Neuropathic Pain

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: HIV-1 Infection, Neuropathic Pain | Phase 3 | Status: TERMINATED | Results posted: 2013-06-27